Skip to content

A study to evaluate the Effectiveness of a Moisturizer on Skin Moisturization.

An Open Label, Single-Arm, Clinical Study to evaluate the Effectiveness of a Moisturizer on Skin Moisturization in adult subjects with mild to moderate acne.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045434
Enrollment
36
Registered
2022-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Moisturizer: Subjects will be instructed to apply approximately 2 gm of test product on the entire face. The product will be spread evenly in a circular motion and the product will be a

Sponsors

Dr Reddys Laboratories Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 18 to 35 years (both inclusive) at the time of consent. 2. Sex: Adult male and non-pregnant/non-lactating female. 3. Subjects with acne-prone skin and with mild to moderate acne condition as per IGA scale for Acne severity. 4. Subjects with oily skin having Sebumeter measurement > 180 (µg/cm2). 5. Subjects with acne marks/spots and visible pores.

Exclusion criteria

Exclusion criteria: 1. Subjects with drug induced acne as disclosed by subjects. 2. Subjects undergoing treatment for skin lightening. 3. Subjects who are receiving topical or systemic treatments. 4. Subjects with any pigmentary disorder including freckles and melasma. 5. Subjects using other marketed skin lightening products during the study period or in the past 6 weeks.

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of test product in improving the skin moisturization using Corneometer® CM 825 / MoistureMeterSCTimepoint: Day 01 (before application) and Day 15 (plus minus 2 days)

Secondary

MeasureTime frame
Exploratory Endpoints: 10.1 To evaluate the effectiveness of test product in reducing skin pigment using 9-point scale by Dermatologist. 10.2 To evaluate the effectiveness of test product in reducing the facial pores using Severity Scoring Scale of Individual Skin Appearance Parameters by Dermatologist. 10.3 To evaluate the effectiveness of test product on reduction / lightening of blemishes using Mexameter® MX 18. 10.4 To evaluate the effectiveness of test product on blemishes and pores using 3D analysis system.Timepoint: Day 01 (before application), Day 15 (plus minus 2 days), Day 30 (plus minus 2 days), Day 45 (plus minus 2 days) and Day 60 (plus minus 2 days);To assess the Subject Satisfaction Questionnaire after product usageTimepoint: Day 15 (plus minus 2 days), Day 30 (plus minus 2 days), Day 45 (plus minus 2 days) and Day 60 (plus minus 2 days);To evaluate Subject Response Index (Perception about Product) after product usageTimepoint: Day 15 (plus minus 2 days), Day 30 (plus minus 2 days), Day 45 (plus minus 2 days) and Day 60 (plus minus 2 days);To evaluate the effectiveness of test product in improving the skin moisturization using Corneometer® CM 825 / MoistureMeterSCTimepoint: Day 01 (before application), Day 30 (plus minus 2 days), Day 45 (plus minus 2 days) and Day 60 (plus minus 2 days);To evaluate the effectiveness of test product in preventing the appearance of new acne by using Investigatorâ??s Global Assessment (IGA) Scale for Acne VulgarisTimepoint: Day 01 (before application), Day 15 (plus minus 2 days), Day 30 (plus minus 2 days), Day 45 (plus minus 2 days) and Day 60 (plus minus 2 days);To evaluate the effectiveness of test product in reducing skin redness using 5-point scale by DermatologistTimepoint: Day 01 (before application), Day 15 (plus minus 2 days), Day 30 (plus minus 2 days), Day 45 (plus minus 2 days) and Day 60 (plus minus 2 days);To evaluate the effectiveness of test product in Restoring/ Improving the skin barrier functi

Countries

India

Contacts

Public ContactDr Rahul Rathod

Dr Reddyâ??s Laboratories Ltd

Monil.yogesh@drreddys.com04049048400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026